
).Baljit shares how INOVIS supports decision-making and ultimately enables us to be a thought partner

How will the Life Sciences integrate software as a medical device? Neha Gupta, Global Digital Product - Ipsen, joined us to share expertise and insight on how this will dramatically impact the industry as a whole.
Late Life Cycle Management : Generic and Biosimilar considerations in 2020 ... and beyond
| – clinical | – regulatory |
| – commercial | – manufacturing |
| – development | – diagnostics |
| – market access | . . . and more |

Over the past 30 years we have conducted research across most core specialty areas, including:
